MaxLinear, Inc. Announces Fourth Quarter 2016 Financial Results and the Acquisition of Marvell's G.hn Business
MAXLINEAR, INC. |
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS |
(in thousands, except per share data) | | | | |
Years Ended | | | |
December 31, 2016 | |
December 31, 2015 | GAAP cost of net revenue | | | $ | 157,842 | | | $ | 144,937 | | Stock-based compensation | | | (210 | ) | | (213 | ) | Performance based equity | | | 10 | | | (256 | ) | Amortization of inventory step-up | | | (5,641 | ) | | (14,244 | ) | Amortization of purchased intangible assets | | | (8,512 | ) | | (4,202 | ) | Impairment of production masks | | | — | | | (153 | ) | Non-GAAP cost of net revenue | | | 143,489 | | | 125,869 | | | | | | | | GAAP R&D expenses | | | 97,745 | | | 85,405 | | Stock-based compensation | | | (13,681 | ) | | (11,739 | ) | Incentive award compensation | | | (722 | ) | | (1,466 | ) | Performance based equity | | | (4,707 | ) | | (4,032 | ) | Amortization of purchased intangible assets | | | (386 | ) | | (405 | ) | Severance charges | | | — | | | (862 | ) | Restricted merger proceeds and contingent consideration | | | (694 | ) | | (834 | ) | Non-GAAP R&D expenses | | | 77,555 | | | 66,067 | | | | | | | | GAAP SG&A expenses | | | 64,454 | | | 77,981 | | Stock-based compensation | | | (7,014 | ) | | (5,744 | ) | Incentive award compensation | | | (137 | ) | | (106 | ) | Performance based equity | | | (2,951 | ) | | (2,086 | ) | Amortization of purchased intangible assets | | | (6,952 | ) | | (24,989 | ) | Acquisition and integration costs | | | (2,424 | ) | | (5,362 | ) | Restricted merger proceeds and contingent consideration | | | (220 | ) | | (129 | ) | Severance charges | | | — | | | (456 | ) | IP litigation costs, net | | | (699 | ) | | (1,460 | ) | Non-GAAP SG&A expenses | | | 44,057 | | | 37,649 | | | | | | | | GAAP IPR&D impairment losses | | | 1,300 | | | 21,600 | | IPR&D impairment losses | | | (1,300 | ) | | (21,600 | ) | Non-GAAP IPR&D impairment losses | | | — | | | — | | | | | | | | GAAP restructuring expenses | | | 3,432 | | | 14,086 | | Restructuring charges | | | (3,432 | ) | | (14,086 | ) | Non-GAAP restructuring expenses | | | — | | | — | | | | | | | | GAAP income (loss) before income taxes | | | 63,690 | | | (42,906 | ) | Total non-GAAP adjustments | | | 59,672 | | | 114,424 | | Non-GAAP income before income taxes | | | 123,362 | | | 71,518 | | | | | | | | GAAP income tax expense (benefit) | | | 2,398 | | | (575 | ) | Tax impact of non-GAAP adjustments | | | (151 | ) | | (224 | ) | Release of valuation allowance due to net deferred liability acquired | | | — | | | 1,757 | | Non-GAAP income tax expense | | | 2,247 | | | 958 | | | | | | | | GAAP net income (loss) | | | $ | 61,292 | | | $ | (42,331 | ) | Total non-GAAP adjustments before income taxes | | | 59,672 | | | 114,424 | | Total tax adjustments | | | (151 | ) | | 1,533 | | Non-GAAP net income | | | $ | 121,115 | | | $ | 70,560 | | | | | | | | Shares used in computing non-GAAP basic net income per share | | | 63,781 | | | 53,378 | | Shares used in computing GAAP diluted net income (loss) per share | | | 67,653 | | | 53,378 | | Dilutive common stock equivalents | | | — | | | 1,962 | | Shares used in computing non-GAAP diluted net income per share | | | 67,653 | | | 55,340 | | Non-GAAP basic net income per share | | | $ | 1.90 | | | $ | 1.32 | | Non-GAAP diluted net income per share | | | $ | 1.79 | | | $ | 1.28 | |
|